2011
DOI: 10.1016/j.molstruc.2011.08.033
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, crystal, computational study and in vitro anti-tuberculosis activity of N-(furan-2-yl-methyl)-N-(phenyl(quinolin-3-yl)methyl) acetamide derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…The target compounds 1 and 2 were synthesized starting from racemic 6‐bromo‐3‐(chloro(phenyl)methyl)‐2‐methoxyquinolin (Scheme ) . (S)‐(−)‐1‐(1‐naphthyl)ethylamine was introduced as a chiral template, and a mixture of diastereomers ( A , B ) may be generated.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The target compounds 1 and 2 were synthesized starting from racemic 6‐bromo‐3‐(chloro(phenyl)methyl)‐2‐methoxyquinolin (Scheme ) . (S)‐(−)‐1‐(1‐naphthyl)ethylamine was introduced as a chiral template, and a mixture of diastereomers ( A , B ) may be generated.…”
Section: Resultsmentioning
confidence: 99%
“…It was also reported that some mefloquine‐based compounds were identified with relatively potent activity against nonreplicating persistent TB, and a remarkable similarity of mefloquine to bedaquiline was found when it was superimposed with bedaquiline replaced hydroxyl group with C–N double bond, and obtained derivative I displaying a better than or equal anti‐TB activity to that of mefloquine . Based on this, some efforts have been made by our group to develop anti‐TB drugs based on structure activity relationship of bedaquiline . Our group replaced the hydroxyl group of bedaquiline with acid amide (Scheme ) considering that the acid amide may fill the same role as hydroxyl group after acid amide–enol tautomerization.…”
Section: Introductionmentioning
confidence: 83%
“…In mefloquine-based compounds, the derivative 1 demonstrated better or equal anti-TB activity to that of mefloquine. Our group has focused on the development of potent anti-tuberculosis drugs [21,22,23,24], and in our preciously studies, we have designed and synthesized bedaquiline analogies which possessed similar spatial molecular structures as bedaquiline. However, in the case of anti-tubercular activity studies, although most compounds demonstrated biological activity, the unsatisfactory result was that all showed lower inhibitory activities than the standard drugs.…”
Section: Introductionmentioning
confidence: 99%